SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-024727
Filing Date
2024-06-21
Accepted
2024-06-21 16:15:36
Documents
15
Period of Report
2024-06-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49642
2 ex10-1.htm EX-10.1 42635
  Complete submission text file 0001493152-24-024727.txt   324482

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE tvgn-20240614.xsd EX-101.SCH 3815
4 XBRL DEFINITION FILE tvgn-20240614_def.xml EX-101.DEF 26691
5 XBRL LABEL FILE tvgn-20240614_lab.xml EX-101.LAB 36844
6 XBRL PRESENTATION FILE tvgn-20240614_pre.xml EX-101.PRE 25315
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5977
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

IRS No.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41002 | Film No.: 241060362
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)